Skip navigation

Chemical alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)

Name alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)
Equivalent Term ACCP (23-40)
Curation Status No associations have been curated for this chemical yet.
MeSH® ID C085058
External Links

Top ↑ Ancestors

1. ChemicalsPolycyclic Compounds Has associated genes Has associated diseases Has associated exposure references Macrocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Peptides, Cyclic Has associated genes Has associated diseases Has associated exposure references alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)
2. ChemicalsAmino Acids, Peptides, and Proteins Has associated genes Has associated diseases Has associated exposure references Peptides Has associated genes Has associated diseases Has associated exposure references Peptides, Cyclic Has associated genes Has associated diseases Has associated exposure references alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)
3. ChemicalsComplex Mixtures Has associated genes Has associated diseases Has associated exposure references Venoms Has associated genes Has associated diseases Snake Venoms Has associated genes Has associated diseases Elapid Venoms Has associated genes Has associated diseases Cobra Venoms Has associated genes Has associated diseases Cobra Neurotoxin Proteins Has associated genes Has associated diseases alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)
4. ChemicalsBiological Factors Has associated genes Has associated diseases Has associated exposure references Toxins, Biological Has associated genes Has associated diseases Has associated exposure references Venoms Has associated genes Has associated diseases Snake Venoms Has associated genes Has associated diseases Elapid Venoms Has associated genes Has associated diseases Cobra Venoms Has associated genes Has associated diseases Cobra Neurotoxin Proteins Has associated genes Has associated diseases alpha-cobratoxin cyclic peptide Cys-23,40 (23-40)

Top ↑ Descendants

None.